Firefly Neuroscience, Inc.
AIFF
$1.08
$0.000.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 5.98% | 17.72% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 5.98% | 17.72% | |||
| Cost of Revenue | -1.14% | 14.78% | |||
| Gross Profit | 14.48% | 21.43% | |||
| SG&A Expenses | -5.81% | -15.08% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.28% | -11.34% | |||
| Operating Income | 1.79% | 16.32% | |||
| Income Before Tax | 1.00% | 19.16% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 1.00% | 19.19% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 1.00% | 19.19% | |||
| EBIT | 1.79% | 16.32% | |||
| EBITDA | 1.93% | 17.09% | |||
| EPS Basic | 25.27% | 35.44% | |||
| Normalized Basic EPS | 21.89% | 29.37% | |||
| EPS Diluted | 25.27% | 35.44% | |||
| Normalized Diluted EPS | 21.89% | 29.37% | |||
| Average Basic Shares Outstanding | 26.81% | 19.22% | |||
| Average Diluted Shares Outstanding | 26.81% | 19.22% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||